When was Multiply Labs founded?

Multiply Labs was founded in 2016 and raised its 1st funding round within a year of its incorporation.

Where is Multiply Labs located?

Multiply Labs is headquartered in San Francisco, United States. It is registered at San Francisco, California.

Who is the current CEO of Multiply Labs?

Fred Parietti of Multiply Labs. They have also founded 1 company.

How many employees does Multiply Labs have?

As of Jun 30, 2026, the latest employee count at Multiply Labs is 76.

Is Multiply Labs a funded company?

Multiply Labs is a funded company, having raised a total of $41.3M across 7 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Aug 20, 2016.

When was the latest funding round of Multiply Labs?

Multiply Labs' latest funding was a $***** Series A round on Apr 21, 2023, with participation from 0 investor.

Where does Multiply Labs rank among its competitors?

Multiply Labs ranks 3rd amongst 27 active competitors, of which 10 are funded. It stands 4th in terms of total funding among its competitors. The most recent competitor to raise funding was Cellares, which secured $50M in Jun, 2026.

Who are the top competitors of Multiply Labs?

Multiply Labs' top competitors include Oribiotech, Cellares and Cellular Origins. Among them, Cellares secured the most recent funding round in June, 2026.

Multiply Labs - 2026 Company Profile, Team, Funding & Competitors

Multiply Labs is a series A company based in San Francisco (United States), founded in 2016 by Alice Melocchi, Tiffany Kuo, Fred Parietti and Joe Wilson. It operates as a Manufacturer of precision medicines through innovative robotic technology. Multiply Labs has raised $41.3M in funding from investors like Y Combinator, Casdin Capital and P101. The company has 27 active competitors, including 10 funded and 1 that has exited. Its top competitors include companies like Oribiotech, Cellares and Cellular Origins.

Company Details

Manufacturer of precision medicines through innovative robotic technology. The company is offering Robotic systems to manufacture gene modified cell therapies at industrial scale. It also, offer a Digital QC an automation software that enables process planning and digital records.

Website: multiplylabs.com
Social
Email ID: *****@multiplylabs.com
Registered Address: San Francisco, California

Key Metrics

Founded Year

2016

Location

San Francisco, United States

Stage

Series A

Total Funding

$41.3M in 7 rounds

Latest Funding Round

Series A, Apr 21, 2023, $*****

Investors

Y Combinator & 23 more

Ranked

3^rd among 27 active competitors

Employee Count

76 as on Jun 30, 2026

Similar Companies

Oribiotech & 26 more

View Multiply Labs' full profile

Multiply Labs is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
MULTIPLY LABS, INC. CIN: 812483725 , United States, Active	Dec 31, 1999	-	34 (As on Dec 31, 2024)	-

Multiply Labs has raised a total funding of $41.3M over 7 rounds. Its first funding round was on Aug 20, 2016. Multiply Labs has 24 institutional investors.

Here is the list of recent funding rounds of Multiply Labs:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Apr 21, 2023	2481527	Series A	5985990	6142923	6011723	2905484
Apr 14, 2021	8915286	Series A	4624487	8203807	8346662	Lux Capital & 3 more
Oct 27, 2018	8197831	Series A	8250473	6494895	8570544	4522568

Access funding benchmarks and valuations. Sign up today!

View details of Multiply Labs's funding rounds and investors

The founders of Multiply Labs are Alice Melocchi, Tiffany Kuo, Fred Parietti and Joe Wilson. Fred Parietti is the CEO of Multiply Labs.

Here are the details of Multiply Labs' key team members:

Alice Melocchi: Co-Founder & CSO of Multiply Labs. They serve on the board of 1 company.
Contact Info: 1 email address
Tiffany Kuo: Co-Founder of Multiply Labs. They serve on the board of 1 company.
Fred Parietti: Co-Founder & CEO of Multiply Labs.
Contact Info: 1 email address
Joe Wilson: Former Co-Founder of Multiply Labs.

Multiply Labs' Board of Directors

Multiply Labs's board has 8 active members. Alice Melocchi, Tiffany Kuo, Michael Doherty, Shaun Rodriguez, Krishnan Viswanadhan, Joseph Siener Wilson, Federico Parietti and Jason Arcediano are independent board members.

Here is the list of Multiply Labs' board of directors:

Name	Type	Representing	Status	Duration
Alice Melocchi	Independent board member	-	Current	9y 2m
qgztvhi	Independent board member	-	Current	9y 8m
qlhsz{p	Independent board member	-	Current	7y 8m
ugqweua	Independent board member	-	Current	9y 7m
vgqcrv{	Independent board member	-	Current	2y 7m
uzflpuw	Independent board member	-	Current	2y 4m
pznkbfc	Independent board member	-	Current	7y 4m
ttemujp	Independent board member	-	Current	4y 2m

View details of Multiply Labs's Founder profiles and Board Members

Multiply Labs' employee count trend

Multiply Labs has 76 employees as of Jun 26. Here is Multiply Labs's employee count trend over the years:

Uncover Multiply Labs' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Multiply Labs include Oribiotech, Cellares and Cellular Origins. Here is the list of Top 10 competitors of Multiply Labs, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Oribiotech 2015, London (United Kingdom), Series B	Biotech company focused on advancing cell and gene therapy manufacturing through innovative automation tool	$281M	Novalis LifeSciences, Northpond Ventures ... & 17 others	66/100
2nd	Cellares 2019, San Francisco (United States), Series D	Manufacturer of a medical device for cell-based therapy	$682M	Eclipse, BlackRock & 17 others	64/100
3rd	Multiply Labs 2016, San Francisco (United States), Series A	Manufacturer of precision medicines through innovative robotic technology	$41.3M	Pegasus Tech Ventures, Graph Ventures & 22 others	64/100
4th	Cellular Origins 2022, Melbourn (United Kingdom), Series A	Provider of automated manufacturing solution for cell and gene therapy	$40M	Johnson & Johnson, The Technology Partnership ... & 3 others	55/100
5th	Astraveus 2016, Paris (France), Seed	Provider of a device for autologous cell and gene therapies	$18M	AdBio partners, Bpifrance & 5 others	55/100
6th	Unicorn Biotechnologies 2020, Sheffield (United Kingdom), Seed	Developer of bioreactors for cell-based manufacturing	$3.2M	Acequia Capital, HAX & 9 others	43/100
7th	Shenzhen Shenyan Biotechnology 2014, Shenzhen (China), Series B	Developer of automated cell processing system	$56.7M	Eight Roads Ventures, Tasly & 3 others	40/100
8th	ThermoGenesis 1986, Rancho Cordova (United States), Public	Provider of automated technologies for cell-based therapeutics and bio-processing	-	Bay City Capital, HHS	40/100
9th	Cell X Technologies 2017, Cleveland (United States), Funding Raised	Developer of regenerative medicine to measure and manage human cell sources	-	Innovation Works, Denniston Family Office ... & 2 others	35/100
10th	Celltrio 2018, Fremont (United States), Series B	Developer of automated biobanking and cell culture systems	$15M	Premier Partners	34/100